About Geneva
Advancing Military Medicine, Ensuring Mission Success
Geneva advances operationally relevant, military-unique research aligned with DoD requirements to ensure mission success. We accelerate military medical Research and Development (R&D) to deliver deployable solutions that enhance the health, readiness, and capabilities of service members and the communities they serve. With deep expertise in research operations, government contracting, strategic collaborations, and commercialization, Geneva ensures successful research outcomes and remains a committed strategic partner in advancing military medicine.
Geneva is committed to securing sustained, predictable growth in funding for medical and biomedical research and to ensuring that all research is conducted in accordance with the highest ethical and scientific standards and meets all applicable regulations. In collaboration with our investigators, Geneva submits research applications to, and administers awards from, notable grant-making bodies.
Mission
Geneva’s mission is to advance military medicine through research, development, and education.
Core Values
Geneva sets itself apart by delivering exceptional service and expertise, driven by a steadfast commitment to shared values: Integrity, Superior Customer Service, Quality, Innovation, Teamwork, and Respect For All.
Our Enduring Impact
This video celebrates Geneva’s 30+ years of progress and achievement, showcasing our journey from the past to the present. It captures the essence of who we are today—an organization committed to excellence—and highlights the vision that drives us forward as we continue to shape the future of military medicine. Our legacy of impact is built on decades of service, innovation, and a relentless pursuit of solutions that improve the health and readiness of service members and the communities they serve.
Watch Now
A Timeline of Our History
Geneva was founded in response to a critical need—to provide military medical researchers and clinicians with the resources required to enhance the lives of our nation’s service members and their families.
In 1996, Elise Huszar, MBA, joined Geneva as Executive Director and has since served as President (1998) and President & CEO (2019), leading the organization through significant growth and impact.
From its inception, Geneva has remained steadfast in its commitment to those we serve and the values that guide us.
2023-Present
2023
Geneva celebrates its 30th anniversary, marking three decades of dedicated service in advancing military medicine, driving research innovation, delivering impactful solutions, and creating meaningful collaborations.
2023
Geneva opens its Frederick, MD-based research management office at the Frederick Innovative Technology Center, marking a significant growth milestone that enhances the organization’s ability to better serve its customers and engage key stakeholders.
2013-2022
2022
The Fort Bragg Research Institute (now the Fort Liberty Research Institute) opens its first physical location at the Fayetteville Cumberland Economic Development Corporation’s CORE Innovation Center, marking a significant growth milestone that enhances the Institute’s capacity to drive innovation and support research.
2022
Geneva is awarded its first subaward from the U.S. Army Combat Capabilities Development Command, Chemical Biological Center (DEVCOM CBC), and prime ERP International to deliver cutting-edge Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) research and development solutions, enhancing the warfighter’s capabilities and advancing national defense efforts.
2021
Geneva is awarded a GSA Schedule under the Multiple Award Schedule (MAS), streamlining the process for serving federal customers and expanding its ability to deliver high-impact solutions to serve its federal customers.
2021
The Biotechnology, Biomanufacturing, and Bioprinting Program (4D Bio3) is elevated by the Uniformed Services University to the USU-4D Bio3 Center for Biotechnology.
2020
Geneva is awarded a subcontract under CRO Pharm-Olam for Operation Warp Speed to support two lead COVID-19 vaccine candidates at six military treatment facilities, playing a critical role in the global pandemic response by accelerating the development of deployable vaccines.
2019
Geneva assumes management of the TriService Nursing Research Program at USU, marking a significant growth milestone that expands its capacity to drive nursing research and innovation.
2019
The Uniformed Services University issues a cooperative agreement to Geneva to facilitate the execution of the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) program, advancing critical research to improve recovery and readiness for service members.
2018
Geneva opens its National Capital Region Office in Bethesda, MD, expanding its presence and strengthening its ability to engage with key federal agencies, partners, and stakeholders to advance military medical research and innovation.
2017
The Uniformed Services University issues a cooperative agreement to Geneva to facilitate the execution of the 4D Biofabrication, Bioprinting, and Biomanufacturing (4DBio3) Program, advancing innovative research in biofabrication technologies with significant potential to enhance military healthcare and shape the future of medical treatments.
2016
Geneva enters into an MOU with the Uniformed Services University to collaborate on multiple initiatives aimed at advancing medical research and education within the DoD, strengthening the organization’s role in enhancing military healthcare and supporting broader medical innovation.
2015
Geneva begins supporting pharmacy resident rotations at Naval Medical Center San Diego in collaboration with the University of California San Diego, and orthopaedic resident rotations at Madigan Army Medical Center and the VA Medical Center in San Francisco in partnership with Samuel Merritt University, enhancing the development of future medical professionals and advancing military and veteran healthcare.
2015
Geneva and the Jonas Center for Nursing and Veterans Healthcare establish a partnership aimed at supporting a doctoral nursing scholar to participate in military medical research with a focus on veteran needs.
2015
Geneva is awarded its first Joint Warfighter Medical Research Program contract to support LTC Luis Alvarez at the National Cancer Institute – Frederick, marking a significant milestone in the organization’s growth and expanding its capacity to support high-impact cancer research.
2014
Geneva is awarded a contract from Naval Medical Logistics Command to support research at Naval Medical Research Center – Frederick, advancing groundbreaking joint research projects in biodefense and infectious diseases with global partners to strengthen military medical preparedness.
2014
Geneva establishes its Researcher of the Year award, recognizing Lt. Col. Vikhyat Bebarta for his pioneering contributions to advancing innovative medical research within the U.S. military, and setting a standard for excellence in military-relevant research.
2013
The signing of the 2014 National Defense Authorization Act marks a critical milestone for Geneva, officially granting privileges to collaborate directly with the Uniformed Services University, expanding its presence within the military medical research community.
2000-2012
2012
Geneva’s continued growth leads to the establishment of its Scientific Advisory Board, providing expert research guidance, ethical oversight, and advocacy to enhance the organization’s impact and uphold the highest standards in research excellence.
2010
Geneva begins collaboration with the DoD Hearing Center of Excellence, fostering critical alliances to provide research, professional, and administrative support services, and advancing efforts to improve auditory health and readiness.
2008
Geneva receives a Congressional Special Interest award to establish Centers for Targeted Radiation Therapy at Madigan Army Medical Center and the VA Puget Sound Health Care System, expanding its presence and advancing innovative cancer research.
2007
Geneva supports its first international study on the development of a malaria vaccine at the Armed Forces Research Institute of Medical Sciences in Thailand, establishing the organization’s presence on a global stage and advancing efforts to combat infectious diseases worldwide.
2006
Geneva secures its first Congressionally Directed Medical Research Program funding to study new treatments for bone infections in critically wounded soldiers, marking the beginning of a long-standing success in advancing innovative medical solutions through CDMRP.
2006
Geneva secures its first National Institutes of Health awards at Walter Reed Army Institute of Research, solidifying its presence in the broader research community and advancing studies in respiratory toxicity and lung injury.
2005
Geneva secures its first federal contract award to establish a Sponsored Research Office at Walter Reed Army Institute of Research, representing a pivotal milestone in the organization’s growth.
2003
Geneva introduces robust proposal development services, establishing a unique capability among non-profit organizations and enhancing its impact by securing funding for critical military-relevant research.
1993-2002
2002
Geneva negotiates a master agreement for research and development with the U.S. Army, expanding its reach and ability to support military-relevant research.
1997
Geneva launches its first multi-center consortium of research under the direction of the Urology Service at Madigan Army Medical Center, fostering collaborative innovation and advancing groundbreaking research to improve medical outcomes.
1996
Geneva’s current President and CEO, Elise Huszar, joins as its first Executive Director, embarking on a distinguished tenure defined by visionary leadership that laid the foundation for the organization’s transformative growth.
1996
Geneva commences management of first federal grant award from the TriService Nursing Research Program, supporting nurse researchers to drive impactful advancements in military nursing practices and improve healthcare outcomes for service members and their families.
1993: Founded
Geneva is founded by Jane Taylor, a critical care nurse, to advance military medicine and provide comprehensive research services to support the needs of Madigan Army Medical Center.
Philanthropy At Geneva
Geneva donors make an impact in advancing critical research and the opportunity for revolutionary change on a global scale. By contributing to Geneva, donors directly support researchers in their pursuit of discovery and innovation in military medicine beyond the reaches of federal research dollars.
Explore Giving Opportunities